General MedicationsORALGeneric
CLOZAPINE
CLOZAPINE
Standard Dose
12.5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview CLOZAPINE is listed in Drugs@FDA under application 075417 (ANDA).
Marketing status: Discontinued Active ingredient CLOZAPINE Form and strength TABLET;ORAL - 12.5MG Sponsor MYLAN Submission history Latest submission status date: 2025-06-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview CLOZAPINE is listed in Drugs@FDA under application 075417 (ANDA). Marketing status: Discontinued Active ingredient CLOZAPINE Form and strength TABLET;ORAL - 12.5MG Sponsor MYLAN Submission history Latest submission status date: 2025-06-13 00:00:00. Submission type: SUPPL.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.